Non-CF Resources and Support

Resources that can help your patients with EPI

Get resources that can help your patients with EPI

Through MySampleCloset, practices are able to easily request:

3 Pills Icon

Samples of ZENPEP® at any strength

Enroll now

To learn more, visit


The ZENPEP Patient Support Program

The ZENPEP Patient Support Program (for patients with EPI due to non-CF conditions) is available for eligible residents of the United States and Puerto Rico. As members, patients can receive:

Money in Hand

Discounted out-of-pocket costs—eligible patients may pay as little as $0 for their first ZENPEP prescription fill and as little as $30 for refills*

Pill in bottle

FREE vitamins and supplements

Clock pill icon

Refill and dosing reminders

Headset Icon

Live support from customer care advocates

To learn more about program registration and savings card activation, visit the ZENPEP Patient Support Program website.

CF=cystic fibrosis; EPI=exocrine pancreatic insufficiency.

*This offer is valid only for ZENPEP prescriptions. Eligible patients may pay as little as $0 per ZENPEP 30-day prescription fill and up to $30 for refills. This offer is valid for up to twelve (12) prescription fills of a 30-day supply. Check with pharmacist for copay discount. Maximum savings limit applies; patient out-of-pocket expense may vary. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs. Please see Non-CF Patient Support Program Terms, Conditions, and Eligibility Criteria at

More than 9 out of 10 patients are covered for ZENPEP1,2§

-Commercial insurance: 92%; Medicare insurance: 95%


§Data are not a guarantee of coverage, or partial or full payment, by any payers listed. Actual benefits determined by respective plan administrators. Insurer plans, coverage criteria, and formularies are subject to change without notice. Check each patient’s coverage with applicable insurer. Nestlé Health Science does not endorse any individual plans. Formulary coverage does not imply efficacy or safety.

References: 1. MMIT Data on File. Nestlé Health Science. Accessed February 1, 2021. 2. MMIT Data on File. Nestlé Health Science. Accessed November 3, 2020.